Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethaselen in Advanced NSCLC
NCT02166242Phase 1Completed
- Sponsor
- Hunan Cancer Hospital
- Start
- Jun 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethaselen in non-small cell lung cancer (NSCLC), sponsored by Hunan Cancer Hospital. Primary endpoint: Disease Control Rate at 6 weeks. Started Jun 2014; status: completed.
02
Drugs
ethaselen
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02166242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166242.